A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making symptom-improving medication more accessible for people experiencing mild cognitive impairment.

Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer’s disease, ALS and other brain diseases, CEO David Ricks said.

Liraglutide is sold under the brand names Saxenda and Victoza, and sales are declining as blockbuster GLP-1s Ozempic and Wegovy skyrocket in demand.

New research suggests certain blood tests could help doctors diagnose Alzheimer’s disease faster and more accurately.

Seth Rogen and his wife Lauren dish started their nonprofit, Hilarity for Charity, 12 years ago when Lauren’s mom was diagnosed with Alzheimer’s disease.

A gene called APOE4 has long been considered a key risk factor. But new research says if people inherit two copies of that gene, it’s not just a risk — it appears to be the underlying cause.

Alzheimer’s disease and related dementias affect about 5.8 million people in the United States, according to a CDC estimate. New York Times bestselling author Lisa Genova’s new novel, “Still Alice,” raises awareness for those affected by Alzheimers. She discusses the perspective that the book offers as well as the film adaptation released in 2014.

Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.

Did you know September is World Alzheimer’s Month? Dr. Kavita Desai explains what the disease is and what we can do know to try and prevent the disease later in life.

The Alzheimer’s Association created a list of early signs of the disease or other types of dementia. In the United States, the disease disproportionately affects Hispanic patients.